BioGend Therapeutics
Blood & Organ Banks · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
TaiwanPhone Number
+886 226558366Website
www.biogend.com.twRevenue
<$5 MillionIndustry
About BioGend Therapeutics
BioGend Therapeutics specializes in innovative medical solutions, particularly in the field of orthopedic regeneration and severe infections. Their flagship product, RevoCart, offers a revolutionary one-time autologous cartilage repair treatment designed for early intervention in degenerative arthritis and knee cartilage wear, eliminating the need for artificial joint replacement. The company aims to enhance the quality of human healthcare by developing internationally competitive pharmaceuticals and medical devices that meet clinical needs. They cater to both individual patients suffering from knee pain and medical institutions seeking advanced treatment options.Explore more
SIC Code 28,283NAICS Code 32,325Show moreBioGend Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
BioGend Therapeutics Tech Stack
A closer look at the technologies used by BioGend Therapeutics
See more technologies
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioGend Therapeutics
Sign Up For FreeTo access detailed company insights
BioGend Therapeutics specializes in innovative medical solutions, particularly in the field of orthopedic regeneration and severe infections. Their flagship product, RevoCart, offers a revolutionary one-time autologous cartilage repair treatment designed for early intervention in degenerative arthritis and knee cartilage wear, eliminating the need... Read More
